000 | 01611 a2200493 4500 | ||
---|---|---|---|
005 | 20250514061040.0 | ||
264 | 0 | _c20030416 | |
008 | 200304s 0 0 eng d | ||
022 | _a1527-9995 | ||
024 | 7 |
_a10.1016/s0090-4295(02)02163-5 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHan, Ken-Ryu | |
245 | 0 | 0 |
_aNumber of metastatic sites rather than location dictates overall survival of patients with node-negative metastatic renal cell carcinoma. _h[electronic resource] |
260 |
_bUrology _cFeb 2003 |
||
300 |
_a314-9 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 |
_aBone Neoplasms _xdiagnosis |
650 | 0 | 4 |
_aCarcinoma, Renal Cell _xmortality |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunotherapy |
650 | 0 | 4 |
_aKidney Neoplasms _xdiagnosis |
650 | 0 | 4 |
_aLung Neoplasms _xdiagnosis |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNeoplasm Metastasis _xpathology |
650 | 0 | 4 | _aNephrectomy |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aSurvival Analysis |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aPantuck, Allan J | |
700 | 1 | _aBui, Matthew H T | |
700 | 1 | _aShvarts, Oleg | |
700 | 1 | _aFreitas, Danielo G | |
700 | 1 | _aZisman, Amnon | |
700 | 1 | _aLeibovich, Bradley C | |
700 | 1 | _aDorey, Frederick J | |
700 | 1 | _aGitlitz, Barbara J | |
700 | 1 | _aFiglin, Robert A | |
700 | 1 | _aBelldegrun, Arie S | |
773 | 0 |
_tUrology _gvol. 61 _gno. 2 _gp. 314-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0090-4295(02)02163-5 _zAvailable from publisher's website |
999 |
_c12394759 _d12394759 |